158 related articles for article (PubMed ID: 2957614)
1. [Active immunoprophylaxis of type B viral hepatitis. Evaluation of the effectiveness of HEVAC-B vaccine in a population at risk].
Tarocco RP; Faro G; Sargiotto A; Visconti C
Minerva Med; 1987 Aug; 78(16):1233-41. PubMed ID: 2957614
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccine: clinical experience.
Tron F
IARC Sci Publ; 1984; (63):279-95. PubMed ID: 6242147
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus and the control of hepatocellular carcinoma.
Blumberg BS
IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
[TBL] [Abstract][Full Text] [Related]
4. [Response to vaccination against the etiologic agent of viral hepatitis B (HBV) in a population at risk].
Lavezzi M; Donati A; Davi D; Carpanelli MC; Farinelli S; Soracco E
Quad Sclavo Diagn; 1987 Jun; 23(2):164-8. PubMed ID: 2967519
[TBL] [Abstract][Full Text] [Related]
5. [HLA and hypo-responsivity to anti-HBV vaccination (genetic study of non-responder subjects to anti-hepatitis B viral vaccine)].
Panichi G; Cappellacci S; Mola A; Morellini M; Lulli P; Pescini A
Boll Ist Sieroter Milan; 1986; 65(6):459-63. PubMed ID: 2953356
[TBL] [Abstract][Full Text] [Related]
6. [Detection of pre-S gene products in HBsAg carriers and in hepatitis B vaccines].
Gerken G; Manns M; Kyriatsoulis A; Hess G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1988 Jul; 26(7):374-9. PubMed ID: 2851893
[TBL] [Abstract][Full Text] [Related]
7. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
[TBL] [Abstract][Full Text] [Related]
8. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
[TBL] [Abstract][Full Text] [Related]
9. An affordable multideterminant plasma-derived hepatitis B virus vaccine.
Prince AM; Vnek J; Brotman B
IARC Sci Publ; 1984; (63):355-72. PubMed ID: 6085626
[TBL] [Abstract][Full Text] [Related]
10. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
11. Vaccination against hepatitis B virus infection in neonates.
Pongpipat D; Suvatte V; Assateerawatts A
Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
[TBL] [Abstract][Full Text] [Related]
12. Strategies for prevention and control of hepatitis B and hepatocellular carcinoma.
Sobeslavsky O
IARC Sci Publ; 1984; (63):271-8. PubMed ID: 6100274
[TBL] [Abstract][Full Text] [Related]
13. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of Engerix-B in healthy Malaysian medical students.
Isahak I; Abdul Malik Y; Hakim AS; Baharin R
Singapore Med J; 1990 Aug; 31(4):314-6. PubMed ID: 2147781
[TBL] [Abstract][Full Text] [Related]
15. Use of hepatitis B virus vaccine in Africa: rationale and practical approaches for effective utilization.
Prince AM
IARC Sci Publ; 1984; (63):337-54. PubMed ID: 6242151
[TBL] [Abstract][Full Text] [Related]
16. The decline of hepatitis B viral infection in South-Western Saudi Arabia.
Ayoola AE; Tobaigy MS; Gadour MO; Ahmad BS; Hamza MK; Ageel AM
Saudi Med J; 2003 Sep; 24(9):991-5. PubMed ID: 12973485
[TBL] [Abstract][Full Text] [Related]
17. Cellular and humoral modifications during response to HBsAg vaccine in healthy subjects: comparison between French and American vaccines.
D'Amelio R; Matricardi PM; Di Addario A; Le Moli S; Paganelli E; Nisini R; Sirianni MC; Fattorossi A; Cherchi M; Gaetano C
Boll Ist Sieroter Milan; 1989; 68(1):57-61. PubMed ID: 2535246
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis B vaccination with the plasma-derived Hevac-B Pasteur vaccine. A comparison of 2 populations: hospital personnel and hemodialysis patients].
Di Giandomenico G; Di Giandomenico FW; Volterrani A
Minerva Med; 1989 Feb; 80(2):149-51. PubMed ID: 2927706
[TBL] [Abstract][Full Text] [Related]
19. [Immune response to plasma-derived hepatitis B vaccine in hospital health personnel of Parma].
Magnani G; Bertoletti A; Calzetti C; Campari M; Pizzaferri P; Schianchi C; Vitali P
Acta Biomed Ateneo Parmense; 1989; 60(1-2):73-9. PubMed ID: 2535096
[TBL] [Abstract][Full Text] [Related]
20. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.
Lo KJ; Tsai YT; Lee SD; Yeh CL; Wang JY; Chiang BN; Wu TC; Yeh PS; Goudeau A; Coursaget P
Hepatogastroenterology; 1985 Apr; 32(2):65-8. PubMed ID: 3159639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
